Zach Scheiner, PhD

Partner

Zach Scheiner is a Partner at RA Capital Management. Zach’s primary responsibilities are to work on both public and private investments and serves as a Board Director for Exo Imaging, LENZ Therapeutics, Nkarta Therapeutics, SpyGlass Pharma, and Sydnexis. Prior to RA Capital, Zach covered the neurology, ophthalmology, and dermatology landscapes. Zach also worked as a Science Officer at the California Institute for Regenerative Medicine. Zach holds a BS in Molecular Biophysics and Biochemistry from Yale University and a PhD in Neurobiology and Behavior from the University of Washington.